• 9 June 2011
  • News
  • By

India Biotech Surges to $4 billion


Grows 21.5% Registers 18,399.34 cr

Biotech Industry in India in FY 2010-11 has picked up critical mass. In dollar terms, the industry has touched the $4 billion mark, clocking 18,399.34 crore. Of this, the biotech industry contributes 17,249.34 crore while the life science education market makes-up for the remaining 1,150 crore. This year, the BioSpectrum ABLE survey has expanded the scope to include the education market survey estimates in the overall industry revenue. In-depth analysis of the education market is under process and will be published in the August 2011 issue of the publication.

The biotech industry in FY 2010-11 clocked 17,249.34 crore, growing 21.5 percent over the last year's revenue of 14,199 crore. The market share across segments has recorded minor changes with BioPharma claiming 61 percent share in the industry revenue. BioAgri remained the fastest growing segment recording 28 percent growth over last year, followed by BioServices (23 percent) and BioPharma (20.7 percent). Many services companies have taken a hit this year on account of changes in the complexion of business at the global level.

The revenue split between exports and domestic sales has also recorded minor shifts ranging between two-to-five percent. The exports across segment made up 51 percent of the overall revenue contributing a total of 8,852.34 crore. The ratio between exports and domestic sales stands at 51:49, which is a sign of a robust industry.

Biocon retained its top slot of No.1 company in the overall revenue ranking, growing at a healthy 26 percent. Of the Top 20 companies, Shantha Biotech and Jubilant Life Sciences faced a drop in revenue while Ankur Seeds has posted a spectacular growth.

The Top 20 fastest growing companies have all recorded a growth of over 29 percent. While the No. 1 company in this list has grown over 400 percent from a small base of 3.8 crore the No 2 company, Ankur Seeds, has grown 197 percent from a fairly decent base of 109.5 crore. No. 3 slot is also occupied by a seed company, Krishidhan Seeds, which grew at 107 crore.

Comparing the growth by region, the south region has caught up with the west, improving its share in the overall Indian biotech industry to 44.22 percent in 2010-11 from 39 percent in 2009-10. The west region's share is 43.60 percent. Top 10 companies in the south have contributed 4,816.47 crore (27 percent) of the total biotechnology industry while Top 10 companies from west have about 21.17 percent of the total industry contributing 3,651.25 crore.

In terms of the number of companies, south continued its dominance with 175 companies, while west has 139 companies and north is yet to cross the 50 figure mark. It has 48 companies. The industry has 362 companies.

Read on for detailed analysis, in the following pages of BioSpectrum.
SURVEY & RANKING METHODOLOGY

  • BioSpectrum conducted this survey jointly with the Association of Biotechnology Led Enterprises (ABLE). BioSpectrum and ABLE have jointly been doing this exercise since 2003 with assistance from CyberMedia Research, the market analysis outfit of CybeMedia, the publisher of BioSpectrum. A detailed questionnaire (survey form) was sent to over 200 companies to capture the needed information for the analysis. This was done during April-May 2011. Companies shared information with us to the extent it was possible by them.
  • The revenues considered for the analysis are biotech products sales and service figures. In several cases, where revenue figures were not available, estimates were arrived in discussion with industry experts. These are denoted (*) as “BioSpectrum Estimates”.
  • This year in the list of Top 20 companies, biotech focused companies across the life sciences spectrum have been considered, including diagnostics space. An overall listing of companies by revenue has been done for your reference.
  • Biotech suppliers' revenues are not considered/included in this analysis.
  • BioPharma segment included products made by fermentation/animal cell culture (not animal extracts) and plant cell culture (not plant extracts).
  • The BioAgri segment analysis includes only the GM seeds and molecular markers and related products. So, the hybrid seeds business is not a part of the agri-business sales values.
  • The BioServices segment analysis includes the contract as well as clinical research services revenue.
  • For all the ranking purposes, we have taken the biotech business only into consideration. Wherever 'TURNOVER' is mentioned, it means, sales turnover from biotech. Therefore, 'turnover' wherever mentioned is not necessarily the total sales turnover of the company.


Biotech Industry Exports vs Domestic
2010-11
Segment Exports Domestic Total % Share Exports % Share Domestic
Biopharma 5535.40 5109.60 10645 52 48
BioServices 2986.29 259.68 3245.97 92 8
BioAgri 74.40 2405.60 2480 3 97
BioIndustrial 150.23 475.71 625.94 24 76
Bioinformatics 106.02 146.41 252.43 42 58
Total 8852.34 8397.00 17249.34 -
-
2009-10
Segment Exports Domestic Total % Share Exports % Share Domestic
Biopharma 4767.66 4061.34 8829 54 46
BioServices 2507.05 131.95 2639 95 5
BioAgri 58.08 1877.92 1936 3 97
BioIndustrial 124.08 439.92 564 22 78
Bioinformatics 73.92 157.08 231 32 68
Total 7530.79 6668.21 14199 53.04 46.96
  • The domestic BioServices market has increased by three percent in 2010-11 over last year's five percent share in the segment revenue
  • BioInformatics companies have increased exports business revenue in 2010-11 to claim 42 percent segment share with more focus on customers in the US & Europe

Top 20 Life Science Companies by Revenue (2010-11)
Rank Company Revenue in Crore Change over
2008-09 (%)
Change over
2009-10 (%)
2010-11 2009-10 2008-09 2010 (%) 2011 (%)
1 Biocon 1483.00 1180.00 912.34 29.34 25.68
2 Serum Institute of India 1041.00 850.00 1114.00 -23.70 22.47
3 Panacea Biotec 928.41 703.10 597.14 17.74 32.05
4 Nuziveedu Seeds 610.00 476.86 363.96 31.02 27.92
5 Reliance Life Sciences* 490.00 450.00 - - 8.89
6 Quintiles India* 476.25 375.00 - - 27.00
7 NovoNordisk 462.00 362.00 316.00 14.56 27.62
8 Rasi Seeds 371.88 358.78 376.84 -4.79 3.65
9 Mahyco* 364.90 312.00 211.12 47.78 16.96
10 Transasia 350.00 186.00 - - 88.17
11 Ankur Seeds 325.00 109.50 80.35 36.28 196.80
12 Syngene International 318.00 252.00 224.60 12.20 26.19
13 Bharat Biotech * 298.34 271.66 241.05 12.70 9.82
14 Indian Immunologicals 283.00 272.75 224.75 21.36 3.76
15 Krishidhan Seeds 276.13 133.23 63.25 110.64 107.26
16 Shantha Biotech* 272.00 334.23 247.00 35.32 -18.62
17 Novozymes South Asia * 242.00 224.00 205.50 9.00 8.04
18 Bharat Serums 226.00 175.00 140.00 25.00 29.14
19 Jubilant Life Sciences 210.00 249.30 241.50 3.23 -15.76
20 EliLilly 204.00 186.72 164.00 13.85 9.25
*BioSpectrum Estimates

  • The Top 20 companies in 2010-11 have grown by an average of 33%, whereas in 2009-10 these grew at an average of 19%
  • The Top 20 companies' list is dominated by biopharma and agri companies
  • Top 20 companies' contribute 54% to the overall industry revenue
  • Agri companies lead the Top 20 tally of the fastest growing companies with over 100 percent growth. In fact, Ankur Seeds recorded a spectacular 197 percent growth
  • Semler Research India has grown over 400 percent from a very small base of 3.8 crore
  • Among the Top 20 companies by revenue, seven companies made it to the list of Top 20 fastest growing companies. Diagnostics company Transasia made the cut here as well
  • Fastest growing 20 companies contributed 17 percent share to the overall industry revenue
Top 20 Life Science Companies by Growth (2010-11)
Rank Company Revenue in Crore Change over
2008-09 (%)
Change over
2009-10 (%)
2010-11 2009-10 2008-09 2010 (%) 2011 (%)
1 Semler Research India 19.70 3.80 -
418.42
2 Ankur Seeds 325.00 109.50 80.35 36.28 196.80
3 Krishidhan Seeds 276.13 133.23 63.25 110.64 107.26
4 Transasia 350.00 186.00 - - 88.17
5 Richcore Life Sciences 7.34 3.91 3.21 - 87.72
6 Metahelix 11.00 6.00 9.67 -37.95 83.33
7 JK Agrigenetics 50.66 32.50 26.00 25.00 55.88
8 Excel Industries 12.13 8.24 7.90 4.30 47.21
9 Anthem Biosciences 78.00 53.00 32.34 63.88 47.17
10 Bayer CropScience* 31.50 22.50 - - 40.00
11 Pfizer (Wyeth India)* 73.35 53.00 37.00 43.24 38.40
12 Themis Medicare* 124.00 90.00 97.50 -7.69 37.78
13 Siro Clinpharm* 202.00 150.00 280.00 -46.43 34.67
14 GlaxoSimtheKline * 163.00 123.34 83.48 47.75 32.16
15 Panacea Biotec 928.41 703.10 597.14 17.74 32.05
16 Dr Reddy's Laboratories* 82.50 62.50 40.00 56.25 32.00
17 Aventis Pharma* 90.00 68.34 36.00 89.83 31.69
18 Zenotech Laboratories 8.56 6.57 8.30 -20.84 30.29
19 Rossari Biotech* 72.00 55.38 - - 30.01
20 Cadila Healthcare 190.59 147.48 93.70 57.40 29.23
*BioSpectrum Estimates

Top 20 Homegrown Life Science Companies by Revenue (2010-11)
Rank Company Revenue in Crore Change over
2008-09 (%)
Change over
2009-10 (%)
2010-11 2009-10 2008-09 2010 (%) 2011 (%)
1 Biocon 1483.00 1180.00 912.34 29.34 25.68
2 Serum Institute of India 1041.00 850.00 1114.00 -23.70 22.47
3 Panacea Biotec 928.41 703.10 597.14 17.74 32.05
4 Nuziveedu Seeds 610.00 476.86 363.96 31.02 27.92
5 Reliance Life Sciences* 490.00 450.00 - - 8.89
6 Rasi Seeds 371.88 358.78 376.84 -4.79 3.65
7 Mahyco* 364.90 312.00 211.12 47.78 16.96
8 Transasia 350.00 186.00 - - 88.17
9 Ankur Seeds 325.00 109.50 80.35 36.28 196.80
10 Syngene International 318.00 252.00 224.60 12.20 26.19
11 Bharat Biotech * 298.34 271.66 241.05 12.70 9.82
12 Indian Immunologicals 283.00 272.75 224.75 21.36 3.76
13 Krishidhan Seeds 276.13 133.23 63.25 110.64 107.26
14 Shantha Biotech* 272.00 334.23 247.00 35.32 -18.62
15 Novozymes South Asia * 242.00 224.00 205.50 9.00 8.04
16 Bharat Serums 226.00 175.00 140.00 25.00 29.14
17 Jubilant Life Sciences 210.00 249.30 241.50 3.23 -15.76
18 Siro Clinpharm* 202.00 150.00 280.00 -46.43 34.67
19 Cadila Healthcare* 190.59 147.48 93.70 57.40 29.23
20 Tulip Group 185.63 182.48 187.09 - 1.73
*BioSpectrum Estimates

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X